Cortechs.ai | Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Cortechs.ai CEO Kyle Frye Featured on SCALE Community Healthcare Technology & Innovation Podcast

We’re excited to share that Kyle Frye, CEO of Cortechs.ai, recently sat down with the SCALE Community Healthcare Technology & Innovation Podcast for an insightful conversation about the future of medical technology. As a market leader and innovator in AI-powered solutions for neurology, radiology, and oncology, Cortechs.ai is transforming healthcare through advanced imaging technologies.

In this episode, Kyle dives into how Cortechs.ai leverages clinical data and machine learning to empower physicians with more accurate and timely diagnostic insights. Listeners will hear about the company’s pioneering advancements, such as their state-of-the-art imaging solutions that improve patient outcomes and streamline clinical workflows.

Key topics discussed include:

  • The impact of AI-powered quantitative MRI in transforming radiology
  • Innovative solutions for neuroimaging and prostate cancer diagnosis
  • How data-driven insights are revolutionizing the decision-making process for physicians
  • The company’s vision for continued innovation in healthcare technology

Don’t miss this engaging conversation with Kyle as he shares how Cortechs.ai is shaping the future of medical imaging and empowering healthcare professionals worldwide.

You can listen to the podcast on:

Tune in to discover how Cortechs.ai is advancing clinical care through cutting-edge technology!

More Resources

05/29/2025

Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 

As imaging becomes more data-driven, tools like NeuroQuant® with DICOM SR support pave the way for smarter, more connected radiology

05/18/2025

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

This new strategic collaboration aims to enhance the quality of care for people living with Alzheimer’s disease.

05/16/2025

Case Study: NeuroQuant® for ARIA: Monitoring ARIA Progression in Early Alzheimer’s Disease

Dr. Suzie Bash highlights how advanced imaging with NeuroQuant for ARIA supported detection and monitoring of ARIA-E and ARIA-H in an 81-year-old patient.

05/13/2025

Dr. Ana M. Franceschi Joins Cortechs.ai Medical Advisory Board

Neuroimaging thought leader to enhance PET/MRI and dementia research impact through AI-powered tools

05/10/2025

All the Ways to Use the NeuroQuant Custom Report

With the ability to select structures from NeuroQuant’s 70+ structure parcellation atlas, the user has the power to truly personalize patient care!

05/04/2025

Introducing NeuroQuant MS Lesion Dynamics Computation: A Clearer Path to Understanding Disease Progression

Discover how the latest NeuroQuant MS update offers a clearer, more intuitive way to track lesion changes and understand disease progression over time.
Scroll to Top